Financing channel feed

Chi­nese cell ther­a­py biotech de­vel­op­ing TIL ther­a­pies rais­es $60M Se­ries B

Last year
China

For­mer Google AI leader lands $100M Se­ries A raise for 'bi­o­log­i­cal soft­ware' start­up

Last year

Mar­i­ana On­col­o­gy, a ra­dio­phar­ma start­up found­ed by top-tier VCs, nabs $175M Se­ries B

Last year

Ex­clu­sive: Two ex-Re­cur­sion lead­ers start Noetik in a bid to fix the bro­ken fun­nel in can­cer drug re­search

Last year
Startups

French biotech Cor­te­ria se­cures $70M to re­vive ex-Sanofi heart drugs 

Last year

UK biotech brings in $226M Se­ries C

Last year

Schott Phar­ma plans Frank­furt Stock Ex­change list­ing by end of year to boost of­fer­ing to in­jectable drug com­pa­nies

Last year
Pharma
Manufacturing

Nim­bus is back for more, rais­ing $210M to fu­el pipeline sev­en months af­ter $4B Take­da deal

Last year

Ex­clu­sive: Khosla Ven­tures leads seed round in mR­NA biotech look­ing to re­verse ag­ing by length­en­ing telom­eres

Last year
Startups

Ole­ma On­col­o­gy re­ceives $180M in to­tal fund­ing

Last year
R&D

Bio­gen se­cures $1.5B loan to fund Rea­ta buy­out, with three-year re­pay­ment sched­ule baked in

Last year
Deals

Stars align as ex-True North team nabs an­oth­er $90M to build out biotech con­stel­la­tion

Last year
Startups

Can­cer care start­up Thyme Care rais­es $60M, beat­ing the odds of rais­ing a Se­ries B dur­ing dig­i­tal health’s fund­ing slow­down

Last year
Startups
Health Tech

Ex­clu­sive: Stem cell sci­en­tist and bit.bio founder launch­es new start­up with goal of ex­tend­ing healthspan by 20 years

Last year
Startups

Scoop: Metageno­mi is prepar­ing for an IPO this fall, in what could jump­start a wave of pub­lic of­fer­ings

Last year
Startups

Hand­ful of biotechs ex­pect­ed to IPO this fall, but many are stuck in ‘hold­ing pat­tern’ un­til 2024

Last year

CEPI to in­vest up to $80M on ChA­dOx vac­cine plat­form, pre­vi­ous­ly used in As­traZeneca/Ox­ford Covid jab

Last year
Coronavirus

Epi­genic Ther­a­peu­tics en­ters crowd­ed glob­al gene ther­a­py mar­ket with $32M Se­ries A

Last year
Startups

i2o Ther­a­peu­tics clos­es $46M Se­ries A, names Kurt Graves as CEO and ac­quires Intar­cia’s twice-re­ject­ed di­a­betes as­set

Last year
People
Startups

For­mer Schrödinger ex­ec launch­es RA Cap­i­tal-backed start­up for AI drug dis­cov­ery

Last year
Startups

Neu­mora's big neu­ro­science plans head to­ward the Nas­daq in sec­ond PhI­II biotech IPO pitch in 24 hours

Last year
Startups

Ra­dio­phar­ma­ceu­ti­cals start­up Rayze­Bio sub­mits IPO pitch, fore­shad­ow­ing ex­pect­ed post-La­bor Day bump in biotech list­ings

Last year
Startups

Cel­lares rais­es $255M as it boosts its own man­u­fac­tur­ing ef­forts

Last year
Manufacturing

Fore scores $75M Se­ries D, tees up new lead­er­ship with ex-El­e­va­tion CEO Shawn Le­land at the helm — for now

Last year
Startups
First page Previous page 27282930313233 Next page Last page
A service from the Financial Times